CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 66 enrolled
Drug / intervention
Continuous Glucose Monitor +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04920058
NCT04920058N/ACompleted
CompareCT.gov

Improving Cognitive-Behavioral and Cardio-Metabolic Health Through Continuous Glucose Monitoring (CGM)

University of South Florida·interventional·Posted Jun 9, 2021·Updated Nov 15, 2022

In Brief

A clinical study evaluating Continuous Glucose Monitor and <Active Comparator?> for Metabolic Syndrome. Completed, enrolled 66 participants across 1 site.

Detailed Summary

The primary focus of this study is to evaluate the role of Continuous Glucose Monitoring (CGM) with Levels Health software as a tool to provide feedback and accountability necessary to create sustainable behavioral changes in nutrition associated with improved metabolic health and resilience against chronic and infectious diseases.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMetabolic Syndrome
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedJun 9, 2021
Enrollment StartMay 10, 2021
Primary CompletionApr 18, 2022
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 5.1 years ago

Interventions

Continuous Glucose Monitordevice

Continuous glucose monitor - a device that monitors blood glucose levels in a continuous closed-loop manner. This can also refer to the process of continuous glucose monitoring

<Active Comparator?>other

\<describe, Comprehensive Wellness Program incorporating a low carbohydrate diet (\<50g/day) and associated education \>